Long‐term follow‐up of patients with <scp>HIV</scp>‐related diffuse large <scp>B</scp>‐cell lymphomas treated in a phase <scp>II</scp> study with rituximab and <scp>CHOP</scp>
Josep‐María Ribera(Universitat Autònoma de Barcelona), Evarist Feliú(Universitat Autònoma de Barcelona), Santiago Gardella(Fundación Pethema), Mireia Morgades(Josep Carreras Leukaemia Research Institute), Eva González‐Barca(Institut Català d'Oncologia), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Eugènia Abella(Hospital Del Mar), Pilar Miralles(Hospital General Universitario Gregorio Marañón), Marta García(Fundación Pethema), Andrés López(Fundación Pethema), Armando López‐Guillermo(Barcelona Supercomputing Center)
Cited by 15
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k